Jiandong Wang Selected Research

EphA5 Receptor

6/2022	Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation.
6/2019	Differential expression of EphA5 protein in gastric carcinoma and its clinical significance.
11/2016	EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiandong Wang Research Topics

Disease

77	Neoplasms (Cancer) 06/2022 - 01/2002
20	Carcinogenesis 06/2022 - 01/2008
18	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2013
17	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2007
17	Carcinoma (Carcinomatosis) 06/2019 - 11/2007
12	Gallbladder Neoplasms (Gallbladder Cancer) 01/2021 - 05/2014
11	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2012
10	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 08/2005
8	Lymphatic Metastasis 01/2021 - 01/2009
7	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 01/2014
7	Stomach Neoplasms (Stomach Cancer) 06/2019 - 01/2002
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 01/2014
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 01/2018
3	Adenocarcinoma of Lung 06/2022 - 08/2013
3	Adenoma (Adenomas) 02/2022 - 01/2009
3	Wounds and Injuries (Trauma) 01/2022 - 01/2015
3	Pancreatitis 11/2021 - 10/2010
3	Disease Progression 12/2020 - 01/2017
3	Triple Negative Breast Neoplasms 11/2020 - 01/2014
3	Papillomavirus Infections 01/2019 - 01/2010
3	Colonic Neoplasms (Colon Cancer) 01/2019 - 08/2005
2	Lung Neoplasms (Lung Cancer) 06/2022 - 01/2015
2	Pain (Aches) 01/2022 - 02/2013
2	Intervertebral Disc Degeneration 01/2021 - 01/2018
2	Hypersensitivity (Allergy) 01/2020 - 12/2016
2	Obesity 01/2019 - 01/2018
2	Infections 01/2019 - 01/2018
2	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 12/2016
2	Glioma (Gliomas) 01/2018 - 02/2011
2	Liver Neoplasms (Liver Cancer) 01/2017 - 05/2014
2	Inflammation (Inflammations) 01/2017 - 07/2007
2	Hemorrhage 10/2016 - 03/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015 - 12/2014
2	Ovarian Epithelial Carcinoma 08/2014 - 01/2014
1	Sarcoma (Soft Tissue Sarcoma) 02/2022
1	Polyps 02/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Rectal Fistula (Anal Fistula) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2007
13	Eph Family Receptors (Eph Receptors)IBA 01/2022 - 01/2008
11	EphrinsIBA 06/2019 - 04/2009
10	Phosphotransferases (Kinase)IBA 01/2018 - 11/2007
9	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2022 - 01/2014
9	EphA1 Receptor (Eph Receptor)IBA 01/2018 - 11/2007
8	Long Noncoding RNAIBA 01/2021 - 12/2014
7	ParaffinIBA 02/2022 - 01/2013
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2014
7	tyrosine receptor (receptor, tyrosine)IBA 01/2018 - 01/2008
6	LigandsIBA 01/2022 - 01/2013
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019 - 11/2007
6	Erythropoietin FDA Link 01/2018 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2015
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2010
4	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018 - 01/2014
4	Messenger RNA (mRNA)IBA 01/2018 - 02/2013
3	EphA5 ReceptorIBA 06/2022 - 11/2016
3	Formaldehyde (Formol)FDA Link 02/2022 - 01/2013
3	EphA7 ReceptorIBA 01/2022 - 11/2007
3	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2013
3	EphB4 ReceptorIBA 01/2019 - 04/2009
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2010 - 11/2007
2	IronIBA 01/2022 - 02/2011
2	TIC10 compoundIBA 01/2022 - 01/2018
2	Polysaccharides (Glycans)IBA 02/2021 - 07/2007
2	3-methylquercetinIBA 01/2021 - 01/2021
2	Coloring Agents (Dyes)IBA 01/2021 - 02/2015
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2018
2	Estrogen ReceptorsIBA 01/2021 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2012
2	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 05/2014
2	Therapeutic UsesIBA 07/2020 - 05/2013
2	AnthracyclinesIBA 01/2020 - 01/2014
2	EnzymesIBA 11/2019 - 08/2005
2	human ERBB2 proteinIBA 01/2019 - 09/2015
2	EphA2 ReceptorIBA 01/2018 - 01/2015
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2013
2	Wnt ProteinsIBA 01/2018 - 03/2017
2	EphA4 ReceptorIBA 01/2017 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 11/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 01/2014
2	Cytochromes c (Cytochrome c)IBA 07/2014 - 08/2012
1	Immune Checkpoint ProteinsIBA 05/2022
1	Chromobox Protein Homolog 5IBA 02/2022
1	Protein Isoforms (Isoforms)IBA 02/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	HomocysteineIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2022

Therapy/Procedure

20	Therapeutics 05/2022 - 07/2007
7	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 11/2020
2	Neoadjuvant Therapy 01/2021 - 01/2018
2	Pedicle Screws 08/2020 - 10/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 01/2017
2	Precision Medicine 04/2016 - 01/2014